CSTONE PHARMA-B: (I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
Mar 28 10:45 ET
CSTONE PHARMA-B: (1) PROPOSED GRANT OF OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP; (2) NOTICE OF EXTRAORDINARY GENERAL MEETING; AND (3) CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING
Dec 28, 2023 04:00 ET
CSTONE PHARMA-B: BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING
Dec 27, 2023 04:00 ET
CSTONE PHARMA-B: GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
Nov 8, 2023 18:00 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 460,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 3,732,500 SHARES
Jun 25, 2023 20:00 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 501,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 3,272,500 SHARES
Jun 8, 2023 20:00 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
May 16, 2023 20:00 ET
CSTONE PHARMA-B: (I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
Mar 23, 2023 10:30 ET
CSTONE PHARMA-B: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Feb 15, 2023 07:00 ET
CSTONE PHARMA-B: (1) PROPOSED RE-GRANTS OF SHARE OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP; (2) PROPOSED GRANT OF SHARE OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP; (3) PROPOSED AMENDMENTS TO THE POST-IPO ESOP; (4)
Feb 14, 2023 07:00 ET
CSTONE PHARMA-B: PLACING OF NEW SHARES UNDER GENERAL MANDATE
Feb 7, 2023 17:14 ET
CSTONE PHARMA-B: (I) PROPOSED CANCELLATION AND RE-GRANTS OF OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP; AND (II) PROPOSED AMENDMENTS TO THE SHARE INCENTIVE SCHEMES
Jan 6, 2023 09:38 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Nov 21, 2022 06:57 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Oct 25, 2022 09:51 ET
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Sep 19, 2022 07:04 ET
CSTONE PHARMA-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO ESOP
Aug 30, 2022 08:00 ET
CSTONE PHARMA-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO ESOP
Jul 21, 2022 06:30 ET
CSTONE PHARMA-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO ESOP
Jun 6, 2022 07:34 ET
CSTONE PHARMA-B: EXCHANGE NOTICE - RESUMPTION OF TRADING
May 31, 2022 20:53 ET
CSTONE PHARMA-B: SUSPENSION OF TRADING IN SHARES
Mar 31, 2022 20:18 ET
No Data
No Data